Aranesp

Active ingredient
Darbepoetin alfa
Medical indication
Epo-Präparat
Pharma Company
Amgen GmbH
Total Number of Doctors1
133 doctors
Total Number of Patients2
8,155 patients
Total minimum fees planned3
498,284.45 €

Observational Studies including Aranesp

Drug No. of doctors1 No. of patients2 Payment per patient3
Aranesp 1 1 570.00 € Einschluss bei Baseline 90 €, Datenerhebung 52 Wochen 480 €
Aranesp 21 42 600.00 € Einschluss Visite: 240, Data Collection month 7-15: 360
Aranesp 6 77 583.00 € für vollständige Datenerhebung + 132 € für EDV-Schulung
Aranesp 16 102 1,667.00 € 15 Dokumentationen
Aranesp n/a 30 450.00 € pro Patient (zzgl. 180 EUR, siehe Vertrag)
Aranesp n/a 150 118.00 € pro Patient, zzgl. 430 EUR einmalig für die Institution (siehe Vertrag)
Aranesp 8 63 1,678.00 €
Aranesp n/a 950 n/a Originalmeldung nicht gefunden
Aranesp 62 950 n/a Meldung vor Anzeigenpflicht
Aranesp n/a 1,500 n/a Meldung vor Anzeigenpflicht
Aranesp / Neulasta / Neupogen 19 281 429.45 €
Aranesp n/a 1,500 n/a Meldung vor Anzeigenpflicht
Aranesp n/a 2,509 n/a Meldung vor Anzeigenpflicht

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.